Stockreport

Regeneron and Sanofi Offer Praluent® (alirocumab) at a New Reduced U.S. List Price

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF TARRYTOWN, N.Y. and BRIDGEWATER, N.J., Feb. 11, 2019 /PRNewswire/ --This is the latest step by the companies to help make Praluent more accessible and affordable for app [Read more]